| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Yohei Shimono | Q57712498 |
| P2093 | author name string | Michael F Clarke | |
| Dalong Qian | |||
| Neethan A Lobo | |||
| P2860 | cites work | Extension of life-span by introduction of telomerase into normal human cells | Q24336088 |
| Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma | Q28286168 | ||
| P921 | main subject | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 675-699 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Annual Review of Cell and Developmental Biology | Q4497277 |
| P1476 | title | The biology of cancer stem cells | |
| P478 | volume | 23 |
| Q64250448 | 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis |
| Q37032148 | A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma |
| Q26744651 | A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells |
| Q91727021 | A Potential Application of Triangular Microwells to Entrap Single Cancer Cells: A Canine Cutaneous Mast Cell Tumor Model |
| Q35685928 | A block in lineage differentiation of immortal human mammary stem / progenitor cells by ectopically-expressed oncogenes |
| Q38071943 | A contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma. |
| Q21999537 | A gene expression profile of stem cell pluripotentiality and differentiation is conserved across diverse solid and hematopoietic cancers |
| Q89982905 | A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets |
| Q38356196 | A major role for microRNAs in glioblastoma cancer stem-like cells |
| Q38749953 | A modified method by differential adhesion for enrichment of bladder cancer stem cells. |
| Q35031330 | A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line. |
| Q36579560 | A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway |
| Q28480928 | A simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growth |
| Q40629103 | A systematic approach to cancer: evolution beyond selection |
| Q34170309 | A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia. |
| Q59059617 | A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours |
| Q39387696 | Aberrant Wnt signaling: a special focus in CNS diseases |
| Q100416095 | Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme |
| Q35931312 | Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation |
| Q41839580 | Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis |
| Q35781533 | Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells |
| Q36799036 | Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells |
| Q36562175 | Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122. |
| Q26751344 | Advances in targeted and immunobased therapies for colorectal cancer in the genomic era |
| Q37474393 | Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients |
| Q83015494 | Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer |
| Q34107750 | Allele-specific disparity in breast cancer |
| Q29615393 | An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors |
| Q36413135 | An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma |
| Q34140296 | Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties |
| Q46416599 | Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid |
| Q38840434 | Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid. |
| Q49517664 | Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer |
| Q36841351 | Arsenic trioxide inhibits cancer stem-like cells via down-regulation of Gli1 in lung cancer |
| Q34593837 | Arsenic, Stem Cells, and the Developmental Basis of Adult Cancer |
| Q37441567 | Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma. |
| Q48917517 | Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population |
| Q91783030 | Asymmetric Division Gene Neurl2 Mediates Twist2 Regulation of Self-Renewal of Mouse Lewis Lung Cancer Stem Cells |
| Q37811896 | Asymmetric cell division: recent developments and their implications for tumour biology |
| Q30596704 | Atypical cell populations associated with acquired resistance to cytostatics and cancer stem cell features: the role of mitochondria in nuclear encapsulation |
| Q91387236 | Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications |
| Q47118752 | Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2. |
| Q52934212 | BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation. |
| Q92134661 | Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells on Tumor Growth and Progression |
| Q37873961 | Biology of hepatic cancer stem cells. |
| Q89765517 | Biophysical Regulation of Cancer Stem/Initiating Cells: Implications for Disease Mechanisms and Translation |
| Q39771415 | Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis |
| Q33474489 | Botryllamides: natural product inhibitors of ABCG2 |
| Q42576930 | Brain cancer stem cells: current status on glioblastoma multiforme |
| Q35932396 | Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs |
| Q37640678 | Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice |
| Q35422357 | CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells |
| Q36007881 | CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells |
| Q53703721 | CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance. |
| Q35176469 | CD117⁺ cells in the circulation are predictive of advanced prostate cancer |
| Q43411083 | CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors |
| Q33546702 | CD133 expression in chemo-resistant Ewing sarcoma cells |
| Q33908271 | CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres |
| Q33793473 | CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells |
| Q35485418 | CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer |
| Q92276491 | CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression |
| Q34936741 | CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population |
| Q36924387 | CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations |
| Q45406868 | CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma |
| Q28084610 | CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells |
| Q37851351 | CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? |
| Q42157221 | CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure |
| Q96135267 | CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway |
| Q37066443 | CXCR4 mediates the proliferation of glioblastoma progenitor cells |
| Q38849212 | CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer |
| Q57293796 | Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues |
| Q39191779 | Can systems biology approach help in finding more effective treatment for acute myeloid leukemia? |
| Q90638405 | Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy |
| Q37699489 | Cancer as a reprogramming-like disease: implications in tumor development and treatment |
| Q83745627 | Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research |
| Q37592247 | Cancer stem cell genomics: the quest for early markers of malignant progression |
| Q60934336 | Cancer stem cell impact on clinical oncology |
| Q38650088 | Cancer stem cell markers: premises and prospects. |
| Q33391372 | Cancer stem cell-directed therapies: recent data from the laboratory and clinic |
| Q37841186 | Cancer stem cells and cancer therapy |
| Q53250527 | Cancer stem cells biomarkers in gastric carcinogenesis. |
| Q37129887 | Cancer stem cells in breast cancer |
| Q42655441 | Cancer stem cells in hepatocellular carcinomas |
| Q37133709 | Cancer stem cells in multiple myeloma. |
| Q37896083 | Cancer stem cells in osteosarcoma: recent progress and perspective |
| Q38713728 | Cancer stem cells in prostate cancer |
| Q34770478 | Cancer stem cells maintain a hierarchy of differentiation by creating their niche |
| Q37398584 | Cancer stem cells: relevance to SCT |
| Q53205314 | Cancer stem-like cells in adenoid cystic carcinoma of salivary glands: relationship with morphogenesis of histological variants. |
| Q57962976 | Cancer: Hedgehog's other great trick |
| Q89930612 | Capicua restricts cancer stem cell-like properties in breast cancer cells |
| Q90327849 | Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol |
| Q38383345 | Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery |
| Q26823028 | Cells of origin and tumor-initiating cells for nonmelanoma skin cancers |
| Q38116928 | Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment |
| Q38174864 | Cellular reprogramming and hepatocellular carcinoma development |
| Q38309029 | Cervical cancer stem cells: opportunities and challenges |
| Q33760216 | Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer |
| Q41664062 | Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature |
| Q34237712 | Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo |
| Q37974613 | Colorectal cancer stem cells |
| Q55411157 | Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. |
| Q26777882 | Common stemness regulators of embryonic and cancer stem cells |
| Q91876718 | Comprehensive characterization of cancer-testis genes in testicular germ cell tumor |
| Q34063075 | Computational analysis of expression of human embryonic stem cell-associated signatures in tumors. |
| Q39138664 | Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells. |
| Q35111874 | Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells |
| Q38205189 | Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages |
| Q33975619 | Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance |
| Q38909074 | Control of stress signaling in stem cells: crossroads of stem cells and cancer |
| Q38511670 | Control of the blood-brain barrier function in cancer cell metastasis |
| Q38759487 | Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells. |
| Q38010167 | Crosstalk among Epigenetic Pathways Regulates Neurogenesis |
| Q36270652 | Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species |
| Q33525413 | Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals |
| Q64276608 | Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions |
| Q50904140 | Dclk1-expressing tuft cells: critical modulators of the intestinal niche? |
| Q28542879 | De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling |
| Q33747762 | Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus |
| Q36251554 | Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease |
| Q41356812 | Defining the mode of tumour growth by clonal analysis |
| Q31112229 | Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines |
| Q65976302 | Delivering Combination Chemotherapies and Targeting Oncogenic Pathways via Polymeric Drug Delivery Systems |
| Q37276138 | Dendritic cells: a critical player in cancer therapy? |
| Q34289152 | Designing Vaccines Based on Biology of Human Dendritic Cell Subsets |
| Q37896429 | Development and maintenance of cancer stem cells under chronic inflammation |
| Q36278425 | Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine |
| Q92962729 | Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma |
| Q37000634 | Developmental signaling pathways in brain tumor-derived stem-like cells. |
| Q34698294 | Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. |
| Q40955994 | Direct cloning and heterologous expression of the salinomycin biosynthetic gene cluster from Streptomyces albus DSM41398 in Streptomyces coelicolor A3(2). |
| Q39467896 | Direct reprogramming of melanocytes to neural crest stem-like cells by one defined factor |
| Q37153084 | Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma |
| Q46233879 | Disruption of mitochondrial complexes in cancer stem cells through nano-based drug delivery: a promising mitochondrial medicine |
| Q21562662 | Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers |
| Q51615425 | Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells. |
| Q34141601 | Downregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells |
| Q29619847 | Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells |
| Q47169621 | Drug Resistance Driven by Cancer Stem Cells and Their Niche |
| Q64252970 | Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Oncogene |
| Q36656385 | Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation. |
| Q41812683 | Dynamic modeling of genes controlling cancer stem cell proliferation |
| Q37274623 | Dysregulated molecular networks in head and neck carcinogenesis |
| Q47267340 | E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis |
| Q54487907 | EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. |
| Q37688603 | ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma |
| Q36328085 | ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex |
| Q37131382 | EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer |
| Q34457148 | Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines |
| Q90704637 | Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines |
| Q36828500 | Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells |
| Q34256683 | Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method |
| Q38155818 | Embryonic stem cell-specific signature in cervical cancer. |
| Q34149945 | Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. |
| Q57150128 | Encapsulation of nor-β-lapachone into poly(d,l)-lactide--glycolide (PLGA) microcapsules: full characterization, computational details and cytotoxic activity against human cancer cell lines |
| Q26765287 | Endometrial stem cells: clinical application and pathological roles |
| Q39628644 | Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells |
| Q42548508 | Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q38898133 | Enriched inhibition of cancer and stem-like cancer cells via STAT-3 modulating niclocelles |
| Q58801250 | Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma |
| Q38014664 | EpCAM and its potential role in tumor-initiating cells |
| Q37045068 | Epidermal stem cells in skin homeostasis and cutaneous carcinomas |
| Q37658825 | Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth |
| Q37132659 | Epigenetic gene silencing in the Wnt pathway in breast cancer |
| Q39932297 | Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells |
| Q34135466 | Epigenetic targeting of ovarian cancer stem cells |
| Q35855269 | Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics |
| Q34790870 | Evaluation of a side population of canine lymphoma cells using Hoechst 33342 dye |
| Q42025395 | Evaluation of cancer stem cell migration using compartmentalizing microfluidic devices and live cell imaging |
| Q39380134 | Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias |
| Q38001627 | Evolving models of tumor origin and progression. |
| Q49986440 | Expression and prognostic significance of doublecortin-like kinase 1 in patients with hepatocellular carcinoma |
| Q42468040 | Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin |
| Q33737393 | Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma |
| Q39272328 | Extensive characterization of sphere models established from colorectal cancer cell lines |
| Q41200574 | FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice |
| Q28269779 | FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer |
| Q36960357 | Faith, heresy and the cancer stem cell hypothesis |
| Q90056649 | Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML |
| Q37981990 | Flow cytometry in cancer stem cell analysis and separation |
| Q89883760 | Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling |
| Q39761002 | Fourier transform infrared (FTIR) spectromicroscopic characterization of stem-like cell populations in human esophageal normal and adenocarcinoma cell lines |
| Q37267202 | From UVs to metastases: modeling melanoma initiation and progression in the mouse. |
| Q34287095 | From single cells to deep phenotypes in cancer |
| Q37808799 | Functional and Clinical Relevance of Chondroitin Sulfate Proteoglycan 4 |
| Q34055092 | Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4 |
| Q36327392 | Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis |
| Q43058652 | Functional modification of adipocytes by grape seed extract impairs their pro-tumorigenic signaling on colon cancer stem cells and the daughter cancer cells |
| Q37632106 | G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration |
| Q36771311 | GLI1 finds a new role in cancer stem cell biology |
| Q37186444 | Gastric cancer stem cells |
| Q38212216 | Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment |
| Q37725726 | Gastric carcinogenesis and the cancer stem cell hypothesis |
| Q37897490 | Gastrointestinal stem cells in self-renewal and cancer |
| Q38103747 | Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells |
| Q36609176 | Genetic approaches identify adult pituitary stem cells. |
| Q40048374 | Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery |
| Q39182910 | Getting to the heart of the matter in cancer: Novel approaches to targeting cancer stem cells |
| Q35156404 | Getting to the source: selective drug targeting of cancer stem cells |
| Q42557592 | Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells. |
| Q48198891 | Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation |
| Q37452665 | Glioma stem cell research for the development of immunotherapy |
| Q34310698 | Gliomagenesis and the use of neural stem cells in brain tumor treatment |
| Q55639950 | Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis. |
| Q38799879 | Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma |
| Q38789755 | Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells |
| Q37535244 | Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. |
| Q38618948 | Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer |
| Q37626925 | H460 non-small cell lung cancer stem-like holoclones yield tumors with increased vascularity. |
| Q33917613 | HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. |
| Q33760690 | HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells |
| Q38583660 | HPV Infection of the Head and Neck Region and Its Stem Cells |
| Q101136375 | HPV+ve/-ve oral-tongue cancer stem cells: A potential target for relapse-free therapy |
| Q39557999 | HTR8/SVneo cells display trophoblast progenitor cell-like characteristics indicative of self-renewal, repopulation activity, and expression of "stemness-" associated transcription factors |
| Q22252312 | Hallmarks of Cancer: The Next Generation |
| Q28084046 | Hepatocellular carcinoma: Where there is unmet need |
| Q38860946 | Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer |
| Q24645020 | Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB |
| Q37575786 | Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse. |
| Q37038655 | Highway to heaven: mammary gland development and differentiation |
| Q38271597 | Histone modifications: Targeting head and neck cancer stem cells |
| Q61813049 | Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells Via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor |
| Q36540434 | Human papillomavirus infections and cancer stem cells of tumors from the uterine cervix. |
| Q37367234 | Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3. |
| Q43130078 | Hypoxia promotes stem cell-like phenotype in multiple myeloma cells |
| Q33670820 | Hypoxic tumor microenvironment and cancer cell differentiation |
| Q37507920 | IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer |
| Q42662335 | ISOLATE: a computational strategy for identifying the primary origin of cancers using high-throughput sequencing |
| Q30662635 | Identification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenes. |
| Q34977042 | Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease. |
| Q39856772 | Identification of gastric cancer stem cells using the cell surface marker CD44. |
| Q34451382 | Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening. |
| Q36762011 | Identification of tumor-initiating cells in a p53-null mouse model of breast cancer |
| Q33506105 | Image-based assessment of growth and signaling changes in cancer cells mediated by direct cell-cell contact |
| Q34676437 | Immune therapeutic targeting of glioma cancer stem cells |
| Q33859251 | Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation |
| Q37971408 | Immunotherapy targeting glioma stem cells--insights and perspectives |
| Q50724690 | Implication of tumor stem-like cells in the tumorigenesis of sporadic paraganglioma. |
| Q37305066 | In search of adrenocortical stem and progenitor cells |
| Q33816271 | In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis |
| Q41681466 | In vitro anticancer drug test: A new method emerges from the model of glioma stem cells. |
| Q38316551 | In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells |
| Q28076101 | In vitro models of cancer stem cells and clinical applications |
| Q26798210 | Increased Oxidative Stress as a Selective Anticancer Therapy |
| Q37250475 | Inflammation and stem cells in gastrointestinal carcinogenesis. |
| Q36299678 | Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases |
| Q38206476 | Influences of vascular niches on hematopoietic stem cell fate |
| Q34027988 | Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation |
| Q35709668 | Inhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines |
| Q64996870 | Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors. |
| Q35572241 | Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer |
| Q37436121 | Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature |
| Q39630342 | Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice |
| Q39429617 | Isolation and characterization of stem-like cells from a human ovarian cancer cell line |
| Q39060277 | Isolation of melanoma cell subpopulations using negative selection |
| Q39055537 | Isolation, identification, and characterization of cancer stem cells: A review |
| Q33952948 | Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance |
| Q28486138 | Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells |
| Q36452206 | Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells |
| Q38857274 | LGR5 promotes the proliferation of colorectal cancer cells via the Wnt/β-catenin signaling pathway |
| Q37904866 | Lessons from common markers of tumor-initiating cells in solid cancers |
| Q35405142 | Lgr5 is a potential prognostic marker in patients with cervical carcinoma |
| Q36995745 | Limitations of the cancer stem cell theory |
| Q47230976 | Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU. |
| Q101476060 | LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness |
| Q37536186 | Localization and Molecular Characterization of human Breast Cancer Initiating Cells from heterogeneous population of Breast Cancer Mesenchymal Stem cells by Immunofluorescence Microscopy |
| Q54959875 | Long Non-Coding RNAs Dysregulation and Function in Glioblastoma Stem Cells. |
| Q53219514 | Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. |
| Q38707291 | Long-Lived Epidermal Cancer-Initiating Cells |
| Q33958108 | Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells |
| Q83367156 | Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis |
| Q98623252 | Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation |
| Q33786637 | Lung cancer stem cell: new insights on experimental models and preclinical data. |
| Q38035056 | Lung cancer stem cells: tumor biology and clinical implications |
| Q47224069 | Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway. |
| Q64226720 | Meeting the Challenge of Targeting Cancer Stem Cells |
| Q61800283 | Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| Q37125569 | Mesenchymal Cells of the Intestinal Lamina Propria |
| Q50001260 | Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. |
| Q35884622 | Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells |
| Q24644251 | MicroRNA let-7: an emerging next-generation cancer therapeutic |
| Q38223219 | MicroRNAs in cancer stem cells: current status and future directions |
| Q43065072 | Minimizing the risk of cancer: tissue architecture and cellular replication limits |
| Q36908928 | Minireview: stem cell contribution to ovarian development, function, and disease |
| Q90177348 | Mitotic quiescence in hepatic cancer stem cells: An incognito mode |
| Q36486600 | Mitotic spindle (DIS)orientation and DISease: cause or consequence? |
| Q46362794 | Model of vascular desmoplastic multispecies tumor growth |
| Q43102307 | Modeling the repertoire of true tumor-specific MHC I epitopes in a human tumor |
| Q28264900 | Modification of mammalian reoviruses for use as oncolytic agents |
| Q94547415 | Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells |
| Q30372789 | Molecular cues on obesity signals, tumor markers and endometrial cancer. |
| Q33917943 | Molecular imaging of metastatic potential |
| Q39120175 | Molecular insights into cancer therapeutic effects of the dietary medicinal phytochemical withaferin A. |
| Q44401200 | Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96. |
| Q39864877 | Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype |
| Q58277244 | Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development |
| Q58577798 | NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells |
| Q90087084 | NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma |
| Q52663155 | NF-κB signaling in cancer stem cells: a promising therapeutic target? |
| Q35833152 | NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib |
| Q38839126 | NK cells control breast cancer and related cancer stem cell hematological spread |
| Q38367692 | Natural product-based therapeutics for the treatment of cancer stem cells: a patent review (2010 - 2013). |
| Q44008507 | Nestin: predicting specific survival factors for breast cancer. |
| Q36453381 | Niche appropriation by Drosophila intestinal stem cell tumours |
| Q34540328 | Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinoma |
| Q49530301 | Nicotine-enhanced stemness and epithelial-mesenchymal transition of human umbilical cord mesenchymal stem cells promote tumor formation and growth in nude mice |
| Q60584710 | Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation |
| Q42560600 | Nonlinear growth kinetics of breast cancer stem cells: implications for cancer stem cell targeted therapy |
| Q39560754 | Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. |
| Q46420352 | Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells. |
| Q38510486 | Novel drug therapies in myeloid leukemia |
| Q59327036 | Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells |
| Q88912678 | Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics |
| Q54658264 | Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway |
| Q30380301 | Of drug administration, war and oïkos: mediating cancer with nanomedicines. |
| Q35597082 | Oncolytic virotherapy for ovarian cancer |
| Q52847842 | Organoid Culture of Human Cancer Stem Cells. |
| Q64040226 | Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases |
| Q37033992 | Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype |
| Q41771086 | Overcoming Multidrug Resistance in Cancer Stem Cells |
| Q35324465 | PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation |
| Q35048897 | PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster |
| Q55280786 | PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma. |
| Q33648865 | Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells |
| Q92705174 | Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma |
| Q51398885 | PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells. |
| Q27438119 | Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer |
| Q33838680 | Postgenomic technologies targeting the Wnt signaling network |
| Q38876097 | Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells |
| Q61453118 | Prognostic Value of CD133 and SOX2 in Advanced Cancer |
| Q41332330 | Prognostic impact of CD133 expression in Endometrial Cancer Patients |
| Q36661089 | Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas |
| Q34467221 | Prognostic value of CD133 expression in stage I lung adenocarcinomas |
| Q36503093 | Prognostic value of cancer stem cell marker CD133 expression in esophageal carcinoma: A meta-analysis |
| Q35055205 | Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis |
| Q34552547 | Progress in understanding melanoma propagation |
| Q39424549 | Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis |
| Q54291180 | Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice. |
| Q38027219 | Proteomics in studying cancer stem cell biology |
| Q34712278 | Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade |
| Q36335412 | Putative cancer-initiating stem cells in cell culture models for molecular subtypes of clinical breast cancer |
| Q90480120 | Quantification of the Underlying Mechanisms and Relationships Among Cancer, Metastasis, and Differentiation and Development |
| Q47097935 | RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer |
| Q91666331 | RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer |
| Q53543624 | Radiation responses of stem cells: targeted and non-targeted effects. |
| Q30540998 | Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells |
| Q38075424 | Redox regulation in stem-like cancer cells by CD44 variant isoforms. |
| Q36960756 | Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities |
| Q37458003 | Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling |
| Q36700030 | Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151. |
| Q35642076 | Regulation of cell growth by Notch signaling and its differential requirement in normal vs. tumor-forming stem cells in Drosophila |
| Q37707515 | Regulation of stem cell function by protein ubiquitylation |
| Q28072716 | Regulatory mechanisms of microRNAs in lung cancer stem cells |
| Q35643960 | Relation of stem cell markers ALDH1 and CD44 with clinicopathological factors in urothelial carcinomas of urinary bladder. |
| Q34154365 | Remodeling of endogenous mammary epithelium by breast cancer stem cells |
| Q39458600 | Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. |
| Q28539523 | Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined |
| Q91705763 | Resveratrol As A Natural Regulator Of Autophagy For Prevention And Treatment Of Cancer |
| Q28541242 | Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway |
| Q37463413 | Revisiting the seed and soil in cancer metastasis |
| Q41613353 | Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway. |
| Q52666361 | Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal. |
| Q47104789 | Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis |
| Q37328360 | Role of oxidative stress in stem, cancer, and cancer stem cells. |
| Q36076413 | SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer |
| Q53224289 | SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. |
| Q90400267 | STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model |
| Q64884695 | SUN2: A potential therapeutic target in cancer. |
| Q28279753 | Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers |
| Q64243717 | Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model |
| Q38768259 | Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines. |
| Q38110297 | Seed, soil, and beyond: The basic biology of brain metastasis |
| Q57282976 | Serially transplantable mammary epithelial cells express the Thy-1 antigen |
| Q36057892 | Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10 |
| Q35233174 | Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells |
| Q92971685 | Signaling pathways involved in chronic myeloid leukemia pathogenesis: The importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells |
| Q27023399 | Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis |
| Q38980557 | Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals |
| Q42733062 | Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness. |
| Q34030957 | Slug and Sox9 cooperatively determine the mammary stem cell state |
| Q28481728 | Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer |
| Q38088823 | Smoothened antagonists: a promising new class of antitumor agents |
| Q34022318 | Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics |
| Q38904884 | Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer |
| Q59792939 | Sox2 is associated with cancer stem-like properties in colorectal cancer |
| Q47726425 | Specific Preferences in Lineage Choice and Phenotypic Plasticity of Glioma Stem Cells Under BMP4 and Noggin Influence. |
| Q28742459 | Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment |
| Q37399843 | Squelching glioblastoma stem cells by targeting REST for proteasomal degradation |
| Q41008891 | Stem Cells in Translational Cancer Research |
| Q35823330 | Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition |
| Q37769649 | Stem cells and cancer of the stomach and intestine |
| Q33989211 | Stem cells in gastroenterology and hepatology |
| Q37193824 | Stemming cancer: functional genomics of cancer stem cells in solid tumors |
| Q81234707 | Stochastic model of the formation of cancer metastases via cancer stem cells |
| Q37612047 | Substrate Stiffness Influences Doxorubicin-Induced p53 Activation via ROCK2 Expression. |
| Q38785852 | Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells |
| Q28076462 | Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment |
| Q38114000 | Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example |
| Q35269551 | Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells. |
| Q41463557 | Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer. |
| Q39321673 | Targeting Lung Cancer Stem Cells: Research and Clinical Impacts |
| Q89667670 | Targeting cancer stem cell pathways for cancer therapy |
| Q48179398 | Targeting cancer stem cells and signaling pathways by resveratrol and pterostilbene. |
| Q89897161 | Targeting cancer stem cells from a metabolic perspective |
| Q35334436 | Targeting cell cycle regulators in hematologic malignancies. |
| Q42317503 | Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer |
| Q26775961 | Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy |
| Q34555251 | Targeting stem cells-clinical implications for cancer therapy |
| Q28078716 | Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling |
| Q36394964 | Targeting the perpetrator: breast cancer stem cell therapeutics |
| Q34069482 | Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate |
| Q47612537 | Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions. |
| Q39071403 | The Cellular Origin and Evolution of Breast Cancer |
| Q36736056 | The Effect of X-Ray and Heavy Ions Radiations on Chemotherapy Refractory Tumor Cells. |
| Q37134198 | The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease. |
| Q57584305 | The Role of Biomaterials on Cancer Stem Cell Enrichment and Behavior |
| Q35684577 | The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"? |
| Q38893314 | The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis |
| Q27005618 | The Role of microRNAs in Stemness of Cancer Stem Cells |
| Q38365386 | The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach |
| Q37787403 | The Tumor Microenvironment and DNA Repair |
| Q26770007 | The Warburg effect and drug resistance |
| Q38092648 | The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics |
| Q53219888 | The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells. |
| Q34681351 | The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance |
| Q90746446 | The biological implications of Yin Yang 1 in the hallmarks of cancer |
| Q38613304 | The biology and clinical implications of prostate cancer dormancy and metastasis |
| Q28244178 | The cancer stem cell niche--there goes the neighborhood? |
| Q36854372 | The cancer stem cell paradigm: a new understanding of tumor development and treatment |
| Q55463049 | The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. |
| Q35566484 | The crossroads between cancer stem cells and aging. |
| Q37649670 | The development of a malignant tumor is due to a desperate asexual self-cloning process in which cancer stem cells develop the ability to mimic the genetic program of germline cells |
| Q36912649 | The differentiation of pancreatic tumor-initiating cells by vitronectin can be blocked by cilengitide |
| Q34310378 | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| Q36730830 | The harmonies played by TGF-β in stem cell biology |
| Q39201926 | The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma |
| Q36538487 | The implications of cancer stem cells for cancer therapy |
| Q36778291 | The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype |
| Q33685563 | The meaning of PIWI proteins in cancer development. |
| Q38018809 | The metastatic niche and stromal progression |
| Q36970312 | The molecular genetics of adrenocortical carcinoma |
| Q37636662 | The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis. |
| Q92528413 | The response of human mesenchymal stem cells to internal exposure to tritium β-rays |
| Q36629170 | The role of biodegradable engineered random polycaprolactone nanofiber scaffolds seeded with nestin-positive hair follicle stem cells for tissue engineering |
| Q35960211 | The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. |
| Q36196598 | The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres |
| Q34785119 | The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells |
| Q28119042 | The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis |
| Q37615918 | Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma |
| Q38783106 | Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention |
| Q38013989 | Tracing epithelial stem cells during development, homeostasis, and repair |
| Q39623731 | Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. |
| Q54360289 | Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. |
| Q90040642 | Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness |
| Q93102744 | Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment |
| Q38584340 | Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? |
| Q27318628 | Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies |
| Q37950602 | Tumor promotion via injury- and death-induced inflammation |
| Q37774865 | Tumor-initiating and -propagating cells: cells that we would like to identify and control |
| Q33668830 | Tumorigenic WAP-T Mouse Mammary Carcinoma Cells: A Model for a Self-Reproducing Homeostatic Cancer Cell System |
| Q24629299 | Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling |
| Q39629096 | Use of multiple biomarkers for the localization and characterization of colon cancer stem cells by indirect immunocytochemistry |
| Q38784131 | Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells |
| Q39627480 | Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line |
| Q26786070 | Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery |
| Q43093172 | What makes cancer stem cell markers different? |
| Q89573138 | When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance |
| Q29619273 | Wnt signalling and its impact on development and cancer |
| Q26745972 | Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication |
| Q38719437 | Zinc suppresses stem cell properties of lung cancer cells through protein kinase C-mediated β-catenin degradation |
| Q89748382 | miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells |
| Q47124421 | miR205 inhibits stem cell renewal in SUM159PT breast cancer cells |
| Q34038397 | microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts |
| Q37419204 | p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. |
| Q33733341 | p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation |
| Q36848635 | β -Elemene-Attenuated Tumor Angiogenesis by Targeting Notch-1 in Gastric Cancer Stem-Like Cells |
| Q30426105 | γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer |
Search more.